379 related articles for article (PubMed ID: 28716801)
21. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.
Fernández-Juárez G; Luño J; Barrio V; de Vinuesa SG; Praga M; Goicoechea M; Lahera V; Casas L; Oliva J;
Clin J Am Soc Nephrol; 2013 Nov; 8(11):1870-6. PubMed ID: 24135218
[TBL] [Abstract][Full Text] [Related]
22. Intervention using vitamin D for elevated urinary albumin in type 2 diabetes mellitus (IDEAL-2 Study): study protocol for a randomised controlled trial.
Taheri S; Asim M; Al Malki H; Fituri O; Suthanthiran M; August P;
Trials; 2018 Apr; 19(1):230. PubMed ID: 29665833
[TBL] [Abstract][Full Text] [Related]
23. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
[TBL] [Abstract][Full Text] [Related]
24. Serum versus Imaging Biomarkers in Friedreich Ataxia to Indicate Left Ventricular Remodeling and Outcomes.
Mehta N; Chacko P; Jin J; Tran T; Prior TW; He X; Agarwal G; Raman SV
Tex Heart Inst J; 2016 Aug; 43(4):305-10. PubMed ID: 27547137
[TBL] [Abstract][Full Text] [Related]
25. Toll/interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction.
Fousteris E; Melidonis A; Panoutsopoulos G; Tzirogiannis K; Foussas S; Theodosis-Georgilas A; Tzerefos S; Matsagos S; Boutati E; Economopoulos T; Dimitriadis G; Raptis S
Cardiovasc Diabetol; 2011 Nov; 10():101. PubMed ID: 22104207
[TBL] [Abstract][Full Text] [Related]
26. Quantitative evaluation of subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus by three-dimensional echocardiography.
Chen X; Guo H; Yang Q; Fang J; Kang X
Int J Cardiovasc Imaging; 2020 Jul; 36(7):1311-1319. PubMed ID: 32277320
[TBL] [Abstract][Full Text] [Related]
27. [Asymptomatic ischemic heart dysfunction, echocardiographic changes and NT-proBNP during 2-years observation].
Skrzypek A; Nessler J
Przegl Lek; 2014; 71(7):378-83. PubMed ID: 25338333
[TBL] [Abstract][Full Text] [Related]
28. Epicardial fat in heart failure patients with mid-range and preserved ejection fraction.
van Woerden G; Gorter TM; Westenbrink BD; Willems TP; van Veldhuisen DJ; Rienstra M
Eur J Heart Fail; 2018 Nov; 20(11):1559-1566. PubMed ID: 30070041
[TBL] [Abstract][Full Text] [Related]
29. N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) for predicting silent myocardial ischaemia in type 2 diabetes mellitus independent of microalbuminuria.
Hamano K; Abe M; Komi R; Kobayashi S
Diabetes Metab Res Rev; 2010 Oct; 26(7):534-9. PubMed ID: 20812386
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic Thresholds for Pre-Diabetes Mellitus and Diabetes Mellitus and Subclinical Cardiac Disease in the General Population:
Myhre PL; Lyngbakken MN; Berge T; Røysland R; Aagaard EN; Pervez O; Kvisvik B; Brynildsen J; Norseth J; Tveit A; Steine K; Omland T; Røsjø H
J Am Heart Assoc; 2021 Jun; 10(11):e020447. PubMed ID: 33998259
[TBL] [Abstract][Full Text] [Related]
31. Left ventricular subclinical myocardial dysfunction in uncomplicated type 2 diabetes mellitus is associated with impaired myocardial perfusion: a contrast-enhanced cardiovascular magnetic resonance study.
Liu X; Yang ZG; Gao Y; Xie LJ; Jiang L; Hu BY; Diao KY; Shi K; Xu HY; Shen MT; Ren Y; Guo YK
Cardiovasc Diabetol; 2018 Oct; 17(1):139. PubMed ID: 30373588
[TBL] [Abstract][Full Text] [Related]
32. Treatment of microalbuminuria in patients with type 2 diabetes mellitus.
Jerums G; MacIsaac RJ
Treat Endocrinol; 2002; 1(3):163-73. PubMed ID: 15799209
[TBL] [Abstract][Full Text] [Related]
33. Relationship between natriuretic peptides and echocardiography parameters in patients with poorly regulated type 2 diabetes.
Dencker M; Stagmo M; Dorkhan M
Vasc Health Risk Manag; 2010 Jun; 6():373-82. PubMed ID: 20539839
[TBL] [Abstract][Full Text] [Related]
34. Effect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria.
Karalliedde J; Maltese G; Hill B; Viberti G; Gnudi L
Clin J Am Soc Nephrol; 2013 Nov; 8(11):1899-905. PubMed ID: 23929932
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and Safety of Imarikiren in Patients with Type 2 Diabetes and Microalbuminuria: A Randomized, Controlled Trial.
Ito S; Kagawa T; Saiki T; Shimizu K; Kuroda S; Sano Y; Umeda Y
Clin J Am Soc Nephrol; 2019 Mar; 14(3):354-363. PubMed ID: 30755452
[TBL] [Abstract][Full Text] [Related]
36. Pioglitazone reduces urinary albumin excretion in renin-angiotensin system inhibitor-treated type 2 diabetic patients with hypertension and microalbuminuria: the APRIME study.
Morikawa A; Ishizeki K; Iwashima Y; Yokoyama H; Muto E; Oshima E; Sekiguchi M; Miura T; Itoh H; Haneda M
Clin Exp Nephrol; 2011 Dec; 15(6):848-53. PubMed ID: 21823043
[TBL] [Abstract][Full Text] [Related]
37. Increased myocardial extracellular volume assessed by cardiovascular magnetic resonance T1 mapping and its determinants in type 2 diabetes mellitus patients with normal myocardial systolic strain.
Cao Y; Zeng W; Cui Y; Kong X; Wang M; Yu J; Zhang S; Song J; Yan X; Greiser A; Shi H
Cardiovasc Diabetol; 2018 Jan; 17(1):7. PubMed ID: 29301529
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal Changes in Cardiac Structure and Function From Adolescence to Young Adulthood in Participants With Type 2 Diabetes Mellitus: The TODAY Follow-Up Study.
TODAY Study Group
Circ Heart Fail; 2020 Jun; 13(6):e006685. PubMed ID: 32498621
[TBL] [Abstract][Full Text] [Related]
39. Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF.
Ehteshami-Afshar S; Mooney L; Dewan P; Desai AS; Lang NN; Lefkowitz MP; Petrie MC; Rizkala AR; Rouleau JL; Solomon SD; Swedberg K; Shi VC; Zile MR; Packer M; McMurray JJV; Jhund PS; Hawkins NM
J Am Heart Assoc; 2021 Feb; 10(4):e019238. PubMed ID: 33522249
[TBL] [Abstract][Full Text] [Related]
40. Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study.
Gulati G; Heck SL; Røsjø H; Ree AH; Hoffmann P; Hagve TA; Norseth J; Gravdehaug B; Steine K; Geisler J; Omland T
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29118031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
